MedTrace Logo

Risk of Hysterectomy at Time of Myomectomy

NCT07365969 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 293

Last updated 2026-01-30

No results posted yet for this study

Summary

Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.

Conditions

  • Myomectomy
  • Fibroid Uterus
  • Hysterectomy

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-15
Primary Completion
2025-10-15
Completion
2025-10-15

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07365969 on ClinicalTrials.gov